Theoretical Model for In Vivo Induction of Chemotherapy Sensitization Using miRNA Packaged in Distinct Layered Liposomes
Source abstract
Abstract
Resistance to chemotherapy is a problem of major social and economic importance, when looking at factors like the decrease in life expectancy, the associated therapeutic costs, and a significant number of cancers that resist current chemotherapy. The development of chemotherapeutics for all theoretically possible tumor variants is an approach that requires unreasonable resources. We propose a theoretical model that serves the purpose of overcoming resistance to chemotherapeutic agents used in cancer therapy. The model describes a gene delivery system based on liposomes, which are optically guided to the tumor’s location. The main aim of the gene delivery system is inhibiting the activity of enzymes involved in drug metabolism, hence offering the opportunity to use inexpensive chemotherapeutics that are already on the market. This model will reduce the costs of chemotherapy and will assure a positive outcome for patients.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomaterials and Medical Devices, Faculty of Medical Engineering, National University of Science and Technology Politehnica Bucharest, 1-7 Gh. Polizu Street, 011061 Bucharest, Romania
Funding
National Program for Research of the National Association of Technical Universities—GNAC ARUT 2023
References (77)
Show source-provided references
1. Cancer Statistics10.3322/caac.21763 ↗
2. Global Cancer Incidence and Mortality Rates and Trends—An Update10.1158/1055-9965.EPI-15-0578 ↗
3. Carbone, A. (2020). Cancer Classification at the Crossroads. Cancers, 12.10.3390/cancers12040980 ↗
4. (2024, April 21). Carcinoma vs. Sarcoma: Location, Prevalence and Prognosis. Available online: https://www.healthline.com/health/carcinoma-vs-sarcoma#location.
5. Sarcoma Treatment in the Era of Molecular Medicine10.15252/emmm.201911131 ↗
6. Overview of Lymphoma Diagnosis and Management10.1016/j.rcl.2008.03.005 ↗
7. Pathogenesis of Myeloma10.1146/annurev-pathol-011110-130249 ↗
8. (2024, April 21). About Leukemia, Available online: https://www.health.ny.gov/statistics/cancer/registry/abouts/leukemia.htm.
9. Caruso, G., Nanni, A., Curcio, A., Lombardi, G., Somma, T., Minutoli, L., and Caffo, M. (2023). Impact of Heavy Metals on Glioma Tumorigenesis. Int. J. Mol. Sci., 24.10.3390/ijms242015432 ↗
10. (2024, April 20). Cancer Staging—NCI, Available online: https://www.cancer.gov/about-cancer/diagnosis-staging/staging.
11. (2024, April 20). Cancer Staging Systems|ACS. Available online: https://www.facs.org/quality-programs/cancer-programs/american-joint-committee-on-cancer/cancer-staging-systems/.
12. Brierley, J.D., Gospodarowicz, M.K., and Wittekind, C. (2017). TNM Classification of Malignant Tumours, John Wiley & Sons, Ltd.. [8th ed.].10.1002/9780471420194.tnmc26.pub3 ↗
13. Managing the Side Effects of Chemotherapy10.1016/0749-2081(89)90080-6 ↗
14. Mechanisms of Drug Resistance in Cancer Chemotherapy10.1159/000086183 ↗
15. Majeed, H., and Gupta, V. (2024). Adverse Effects of Radiation Therapy, StatPearls Publishing.
16. Recent Advances in Radiotherapy and Its Associated Side Effects in Cancer—A Review10.1186/s41936-019-0083-5 ↗
17. Cardiac Side-Effects From Breast Cancer Radiotherapy10.1016/j.clon.2015.06.007 ↗
18. A Review of Proton Therapy—Current Status and Future Directions10.1002/pro6.1149 ↗
19. Mitra, S., Lami, M.S., Ghosh, A., Das, R., Tallei, T.E., Islam, F., Dhama, K., Begum, M.Y., and Aldahish, A. (2022). Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?. Cancers, 14.10.3390/cancers14030759 ↗
20. Economic Burden of Cancer across the European Union: A Population-Based Cost Analysis10.1016/S1470-2045(13)70442-X ↗
21. Cancer Vaccines10.1136/bmj.h988 ↗
22. Functional Significance of the Perforin/Granzyme Cell Death Pathway10.1038/nri911 ↗
23. Interferon-γ: An Overview of Signals, Mechanisms and Functions10.1189/jlb.0603252 ↗
24. Inhibition of Angiogenesis
25. The Challenge of Drug Resistance in Cancer Treatment: A Current Overview10.1007/s10585-018-9903-0 ↗
26. The Radiotherapeutic Injury-a Complex “Wound”10.1016/S0167-8140(02)00060-9 ↗
27. Toxicity of Cancer Therapy: What the Cardiologist Needs to Know about Angiogenesis Inhibitors10.1136/heartjnl-2018-313726 ↗
28. Surgery for Cancer: A Trigger for Metastases10.1158/0008-5472.CAN-16-1536 ↗
29. Hormone Therapy after Endometrial Cancer
30. Yang, L., Yu, H., Dong, S., Zhong, Y., and Hu, S. (2017). Recognizing and Managing on Toxicities in Cancer Immunotherapy. Tumor Biol., 39.10.1177/1010428317694542 ↗
31. Mattioli, R., Maggiore, A., Di Risola, D., Federico, R., D’Erme, M., Francioso, A., and Mosca, L. (2023). Natural Deep Eutectic Solvents Protect RNA from Thermal-Induced Degradation. Arch. Biochem. Biophys., 745.10.1016/j.abb.2023.109714 ↗
32. Non-Coding RNA10.1093/hmg/ddl046 ↗
33. Non-Coding RNA in Cancer10.1042/EBC20200032 ↗
34. Synthesis-Mediated Release of a Small RNA Inhibitor of RNA Polymerase10.1126/science.1134830 ↗
35. Noncoding RNA for Cancer Gene Therapy10.1007/978-3-319-42934-2_4 ↗
36. Drug-Metabolizing Enzymes: Role in Drug Resistance in Cancer10.1007/s12094-020-02325-7 ↗
37. Molecular Mechanism of Phase I and Phase II Drug-Metabolizing Enzymes: Implications for Detoxification10.1016/S0074-7696(06)60002-8 ↗
38. Messenger RNA Regulation: To Translate or to Degrade10.1038/sj.emboj.7601977 ↗
39. A Brave New World of RNA-Binding Proteins10.1038/nrm.2017.130 ↗
40. RNA–Protein Interactions: An Overview10.1007/978-1-62703-709-9_23 ↗
41. Liposomes as Advanced Delivery Systems for Nutraceuticals
42. Cationic Compounds Used in Lipoplexes and Polyplexes for Gene Delivery10.1016/j.jconrel.2004.08.019 ↗
43. DOTAP (and Other Cationic Lipids): Chemistry, Biophysics, and Transfection10.1615/CritRevTherDrugCarrierSyst.v21.i4.10 ↗
44. DMRIE-C Reagent for Transfection of Suspension Cells and for RNA Transfections
45. Luna, A.C.d.L., Saraiva, G.K.V., Chierice, G.O., Hesse, H., and Maria, D.A. (2018). Antiproliferative and Proapoptotic Effects of DODAC/Synthetic Phosphoethanolamine on Hepatocellular Carcinoma Cells. BMC Pharmacol. Toxicol., 19.10.1186/s40360-018-0225-2 ↗
46. Doskocz, J., Dałek, P., Przybyło, M., Trzebicka, B., Foryś, A., Kobyliukh, A., Iglič, A., and Langner, M. (2021). The Elucidation of the Molecular Mechanism of the Extrusion Process. Materials, 14.10.3390/ma14154278 ↗
47. The Use of Extrusion Technology for Encapsulation of Bioactive Components for Their Improved Stability and Bioavailability10.1108/NFS-04-2022-0125 ↗
48. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes10.1016/0005-2736(79)90085-3 ↗
49. (2024, March 27). Mini-Extruder Extrusion Technique|Avanti Polar Lipids (En-US). Available online: https://avantilipids.com/divisions/equipment-products/mini-extruder-extrusion-technique.
50. Thin-Film Hydration Followed by Extrusion Method for Liposome Preparation10.1007/978-1-4939-6591-5_2 ↗
51. The Influence of Phospholipid on the Physicochemical Properties and Anti-Tumor Efficacy of Liposomes Encapsulating Cisplatin in Mice Bearing C26 Colon Carcinoma10.1016/j.ijpharm.2014.07.020 ↗
52. Liposome Formulations with Prolonged Circulation Time in Blood and Enhanced Uptake by Tumors10.1073/pnas.85.18.6949 ↗
53. Liposome: Classification, Preparation, and Applications10.1186/1556-276X-8-102 ↗
54. Application of Magnetic Beads in Bioassays
55. Magnetic Nanoparticles: Preparation, Physical Properties, and Applications in Biomedicine10.1186/1556-276X-7-144 ↗
56. Synthesis of Magnetic Alginate Beads Based on Maghemite Nanoparticles for Pb(II) Removal in Aqueous Solution10.1016/j.jiec.2012.02.018 ↗
57. Oliveira, R.R., Cintra, E.R., Sousa-Junior, A.A., Moreira, L.C., da Silva, A.C.G., de Souza, A.L.R., Valadares, M.C., Carrião, M.S., Bakuzis, A.F., and Lima, E.M. (2023). Paclitaxel-Loaded Lipid-Coated Magnetic Nanoparticles for Dual Chemo-Magnetic Hyperthermia Therapy of Melanoma. Pharmaceutics, 15.10.3390/pharmaceutics15030818 ↗
58. (2024, March 17). Heparin Magnetic Particles—CD Bioparticles. Available online: https://www.cd-bioparticles.com/product/heparin-list-241.html.
59. Precipitation of RNA with Ethanol
60. Yoon, Y., Kim, S., Lee, J., Choi, J., Kim, R.K., Lee, S.J., Sul, O., and Lee, S.B. (2016). Clogging-Free Microfluidics for Continuous Size-Based Separation of Microparticles. Sci. Rep., 6.10.1038/srep26531 ↗
61. (2024, March 30). One of PEG Applications: Surface Modification|Biopharma PEG. Available online: https://www.biochempeg.com/article/63.html.
62. Polyborane-Encapsulated Pegylated Liposomes Prepared Using Post-Insertion Technique for Boron Neutron Capture Therapy10.5650/jos.ess19218 ↗
63. Polyethylene Glycol (PEG): A Versatile Polymer for Pharmaceutical Applications10.1080/17425247.2016.1182485 ↗
64. Normal Body Temperature: A Systematic Review10.1093/ofid/ofz032 ↗
65. Five Parameters You Must Understand to Master Control of Your Laser/Light-Based Devices10.1177/1090820X13501174 ↗
66. (2024, March 17). Ultraviolet Radiation, Available online: https://ehs.lbl.gov/resource/documents/radiation-protection/non-ionizing-radiation/ultraviolet-radiation/.
67. Zhuo, S., Zhang, F., Yu, J., Zhang, X., Yang, G., and Liu, X. (2020). PH-Sensitive Biomaterials for Drug Delivery. Molecules, 25.10.3390/molecules25235649 ↗
68. What Is PH Regulation, and Why Do Cancer Cells Need It?10.1007/s10555-018-09778-x ↗
69. Nishino, M., Matsuzaki, I., Musangil, F.Y., Takahashi, Y., Iwahashi, Y., Warigaya, K., Kinoshita, Y., Kojima, F., and Murata, S. (2020). Measurement and Visualization of Cell Membrane Surface Charge in Fixed Cultured Cells Related with Cell Morphology. PLoS ONE, 15.10.1371/journal.pone.0236373 ↗
70. Cationic Liposomes as Non-Viral Carriers of Gene Medicines: Resolved Issues, Open Questions, and Future Promises10.1002/med.20090 ↗
71. A Brief Study on Liposomes
72. Cooper, G.M. (2000). The Cell: A Molecular Approach. The Cell: A Molecular Approach, Sinauer Associates. [2nd ed.].
73. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., and Walter, P. (2002). From DNA to RNA. Molecular Biology of the Cell, Garland Science. [4th ed.].
74. Biodegradable Cationic and Ionizable Cationic Lipids: A Roadmap for Safer Pharmaceutical Excipients10.1002/smll.202206968 ↗
75. Zhong, K., Shi, Y., Gao, Y., Zhang, H., Zhang, M., Zhang, Q., Cen, X., Xue, M., Qin, Y., and Zhao, Y. (2023). First-Line Induction Chemotherapy with High-Dose Methotrexate versus Teniposide in Patients with Newly Diagnosed Primary Central Nervous System Lymphoma: A Retrospective, Multicenter Cohort Study. BMC Cancer, 23.10.1186/s12885-023-11268-5 ↗
76. Contrast-Induced Nephropathy10.1002/ccd.21207 ↗
77. Toxicity of Cationic Lipids and Cationic Polymers in Gene Delivery10.1016/j.jconrel.2006.04.014 ↗